Illés Árpád

1.

Jóna, Á., Tóthfalusi, D., Illés, Á., Miltényi, Z.: Bispecific Antibodies in B-Cell Lymphomas: mechanisms, Efficacy, Toxicity, and Management.
Medicina (Kaunas). 62 (2), 1-17, (article identifier: 342), 2026.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous) (2025)

2.

Borics, F., Szabó, R., Barna, S., Bedekovics, J., Brúgós, B., Illés, Á., Miltényi, Z.: Hodgkin Lymphoma With Liver Involvement (Diagnostic, Therapeutic Difficulties, and Literature Review): a Retrospective Cohort Study.
Health Science Reports. 9 (1), 1-8, (article identifier: 71716), 2026.

doi DEA Scopus

Journal metrics:

Q2 Medicine (miscellaneous) (2025)

3.

Kiss, E., Illés, Á., Szász, R., Kovács, A. R., Méhes, G., Brúgós, B.: Hodgkin Variant Richter's Transformation in the Absence of Classical Risk Factors: a Rare Case With Spinal Manifestation.
Cureus. 18 (2), 1-9, (article identifier: 103575), 2026.

doi DEA

4.

Brúgós, B., Kerecsenyi, M., Simon, Z., Illés, Á.: Occurrence of cold agglutinin disease among patients with autoimmune hemolytic anemia- a Hungarian single-center experience.
Transfus. Med. Hemother. [Epub ahead of print], 2026.

doi DEA

Journal metrics:

Q2 Hematology (2025)

Q3 Immunology and Allergy (2025)

5.

Obajed Al-Ali, N., Csige, D., Pinczés, L. I., Farkas, K., Rebenku, I., Domján, A., Panyi, G., Szekanecz, Z., Szűcs, G., Illés, Á., Váróczy, L.: Adipokines as Prognostic Biomarkers in Multiple Myeloma: a Case-Control Study.
Medicina (Kaunas). 61 (11), 1-13, (article identifier: 2065), 2025.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

6.

Brúgós, B., Csirmaz, A., Major, T., Bereczky, Z., Gindele, R., Balogh, G., Kacska, S., Sipos, P., Illés, Á., Pfliegler, G.: Antiangiogenic Treatment of Patients with Hereditary Hemorrhagic Telangiectasia: experience of a Hungarian Center.
J. Clin. Med. 14 (22), 1-12, (article identifier: 8160), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

7.

Illés, Á.: Aplasticus anaemia.
In: Hematológia : Egyetemi jegyzet. Szerk.: Gergely Lajos, Miltényi Zsófia, Váróczy László, Debreceni Egyetemi Kiadó, Debrecen, 83-87, 2025. ISBN: 9789636152529

DEA

8.

Domingo-Domenech, E., Horwitz, S., Pro, B., Illidge, T., Trumper, L., Iyer, S., Advani, R., Bartlett, N. L., Christensen, J. H., Kim, W. S., Feldman, T., Choi, I., Gritti, G., Belada, D., Shustov, A., Illés, Á., Zinzani, P. L., Hüttmann, A., Trneny, M., Le Gouill, S., Jagadeesh, D., Friedberg, J. W., Little, M., Dong, C., Fanale, M., Fenton, K., Savage, K. J.: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up.
Blood Cancer J. 15 (1), 1-5, (article identifier: 129), 2025.

doi DEA WoS

Journal metrics:

D1 Hematology

D1 Oncology

9.

Pinczés, L. I., Tóthfalusi, D., Dobó, B., Barna, S., Farkas, B., Garai, I., Illés, Á., Miltényi, Z.: [delta]SUVmax adds prognostic value to early response assessment during the first-line treatment of classical Hodgkin lymphoma: a retrospective cohort study.
Cancer Imaging. 25 (1), 1-8, (article identifier: 80), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Oncology

Q1 Radiological and Ultrasound Technology

Q1 Radiology, Nuclear Medicine and Imaging

10.

Jóna, Á., Kiss, E., Simon, Z., Illés, Á.: Evaluation of PET/CT during upfront therapy as a prognosticator in follicular lymphoma patients at the University of Debrecen.
Blood. 146 (Suppl.), 5348, 2025.

doi DEA

11.

Brown, J. R., Seymour, J. F., Jurczak, W., Aw, A., Wach, M., Illés, Á., Tedeschi, A., Owen, C., Skarbnik, A. P., Lysak, D., Eom, K. S., Simkovic, M., Pavlovsky, M. A., Kater, A. P., Eichhorst, B., Miller, K., Munugalavadla, V., Yu, T., Borja, M. d., Ghia, P., AMPLIFY investigators: Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
N. Engl. J. Med. 392 (8), 748-762, 2025.

doi DEA WoS Scopus

Journal metrics:

D1 Medicine (miscellaneous)

12.

Illés, Á.: Hodgkin lymphoma.
In: Hematológia. Szerk.: Gergely Lajos, Miltényi Zsófia, Váróczy László, Debreceni Egyetemi Kiadó, Debrecen, 150-155, 2025. ISBN: 9789636152529

DEA

13.

Illés, Á., Miltényi, Z.: Hodgkin-lymphoma, aplasticus anaemia.
In: Klinikai immunológia. Szerk.: Szekanecz Zoltán, Nagy György, Szűcs Gabriella, Medicina Könyvkiadó Zrt., Budapest, 783-790, 2025. ISBN: 9789632269467

DEA

14.

Tóthfalusi, D., Gulyás, A., Koncz, A., Zöld, É., Illés, Á., Miltényi, Z.: Hodgkin Lymphoma Associated with Common Variable Immunodeficiency: the Role of Early Diagnosis and Multidisciplinary Management.
Hematol Rep. 17 (6), 1-15, (article identifier: 65), 2025.

doi DEA

Journal metrics:

Q3 Hematology

15.

Tóthfalusi, D., Dobó, B., Borics, F., Pinczés, L. I., Illés, Á., Miltényi, Z.: Impact of Comorbidities on Prognosis and Treatment Outcomes in Elderly Patients with Hodgkin Lymphoma.
Clinics and Practice. 15 (1), 1-16, (article identifier: 15), 2025.

doi DEA Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

16.

Virga, I., Kósa, K., Illés, A., Miltényi, Z., Ivánka, T., Berecz, R., Égerházi, A., Illés, Á., Magyari, F.: Longitudinal study of cognitive andmental functions among adult Hodgkin-lymphoma survivors, based on data from a primary treatment center in Hungary.
Front Oncol. 15, 1-14, (article identifier: 1509424), 2025.

doi DEA

Journal metrics:

Q2 Cancer Research

Q2 Oncology

17.

Jóna, Á., Kiss, E., Illés, Á.: Prognostication of Follicular Lymphoma: a Review of Prognostic Scores and Factors.
Diagnostics. 15 (5), 1-17, (article identifier: 647), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Clinical Biochemistry

Q2 Internal Medicine

18.

Kiss, E., Simon, Z., Illés, Á., Jóna, Á.: Prognostic Significance of Interim PET/CT in the First-Line Treatment of Follicular Lymphoma Patients, a Single-Center Experience.
Cancers (Basel). 17 (1), 1-10, (article identifier: 73), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

19.

László, T., Pinczés, L. I., Bátai, B., Varga, L., Timár, B., Gulyás, A., Tárkányi, I., Plander, M., Nagy, Z., Rajnics, P., Egyed, M., Molnár, Z., Rottek, J., Masszi, A., Tamáska, P., Szász, R., Illés, Á., Alpár, D., Magyari, F., Bödör, C.: Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy.
J. Pathol. 266 (4-5), 395-404, 2025.

doi DEA WoS Scopus

Journal metrics:

D1 Pathology and Forensic Medicine

20.

Kiss, E., Illés, Á., Jóna, Á.: Response Duration During Treatment of Patients with Follicular Lymphoma.
Biomedicines. 13 (6), 1-10, (article identifier: 1433), 2025.

doi DEA

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

21.

Jóna, Á., Illés, Á.: Sequencing Cellular Therapies in the Management of Follicular Lymphoma.
Cells. 14 (21), 1-15, (article identifier: 1671), 2025.

doi DEA

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

22.

Kenyeres, A., Szabó, I. L., Bádon, E. S., Illés, Á., Jóna, Á.: Severe Iron Deficiency Anemia Caused by Long-lasting Bedbug Infestation.
Fortune J. Health Sci. 8 (3), 778-781, 2025.

doi DEA

23.

Németh, R., Bicskó, R. R., Nyilas, R., Illés, Á., Gergely, L.: Van lehetőség a kemoterápián túl: egy idős, relabáló diffúz nagy B-sejtes limfómás betegünk sikeres kemoterápia-mentes kezelése.
Hematol. Trasnzfuziol. 58 (4), 285-288, 2025.

doi DEA

24.

Garami, G., Obajed, A. A. O., Virga, I., Gulyás, A., Bedekovics, J., Tornai, I., Illés, Á., Magyari, F.: Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation.
Curr Oncol Rep. 32 (2), 1-10, (article identifier: 63), 2025.

doi DEA

Journal metrics:

Q1 Oncology

25.

Obajed, A. A. O., Pfliegler, G., Magyari, F., Borics, F., Pinczés, L. I., Illés, Á., Brúgós, B.: A Case Report of Hyperhemolytic Syndrome in Sickle Cell Disease, with a Special Focus on Avoiding the Use of Transfusions.
Thalass. Rep. 14 (1), 18-25, 2024.

doi DEA WoS

Illés Árpád

Publication list